Blinatumomab and better BCR::ABL1 inhibition begets better bone marrow transplant outcomes
Not available.
Saved in:
| Main Authors: | Marlise R. Luskin, Jessica T. Leonard |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-06-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/12112 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CDK6 kinase inhibition unmasks metabolic dependencies in BCR::ABL1+ leukemia
by: Lisa Scheiblecker, et al.
Published: (2025-02-01) -
Precision Medicine in BCR-ABL1 Negative Myeloproliferative Neoplasms
by: Linet Njue, et al.
Published: (2020-12-01) -
Acute Myeloid Leukemia with Concomitant BCR-ABL and NPM1 Mutations
by: Benedetta Mariotti, et al.
Published: (2019-01-01) -
Current and future of targeted therapies against BCR::ABL kinases
by: Sridhar Jayavel, et al.
Published: (2025-04-01) -
Association of Clinical Features and Hematological Laboratories between Ph (+)/BCR-ABL (+) Chronic Myeloid Leukemia and Other Type of Ph/BCR-ABL Chronic Myeloid Leukemia
by: Wulyo Rajabto, et al.
Published: (2018-03-01)